ECE2011 Oral Communications Bone/Reproduction (6 abstracts)
Evolution of neurobehavioral and cognitive symptoms in patients with primary hyperparathyroidism belonging to the Swiss primary hyperparathyroidism cohort
A Trombetti 1 , C Meier 2 , G Gold 1 , C Torriani 1 , C Henzen 3 , F R Herrmann 1 , E R Christ 5 , M Braendle 4 , M E Kraenzlin 2 & R Rizzoli 1
1University Hospital, Geneva, Switzerland; 2University Hospital, Basel, Switzerland; 3Kantonspital, Luzern, Switzerland; 4Kantonspital, St Gallen, Switzerland; 5University Hospital, Bern, Switzerland.
Objective: To describe the evolution of neurobehavioral and cognitive symptoms in patients with primary hyperparathyroidism as measured by mini-mental state (MMS), Hamilton’s anxiety and depression scale (HADS) and Clock tests. Scores were also compared with biochemical data.
Methods: The Swiss primary hyperparathyroidism (PHPT) Cohort Study is an ongoing, prospective, non-interventional national project collecting clinical, biochemical and outcome data in patients with PHPT. Newly diagnosed patients were enrolled. All three tests applied were interpreted centrally. Thereafter, follow-up data were recorded every 6 months as recommended by the NIH guidelines at the time of study onset. The tests were re-administered on a yearly basis. Patients with parathyroidectomy had one follow-up visit 3 to 6 months after surgery. We applied a multiple regression model comparing test results with serum calcium, serum parathyroid hormone (PTH) and serum 25-hydroxyvitamin D, adjusting for age and gender.
Results: From June 2007 to December 2010, 253 patients (mean age 68.8±14.5 years; 77.5% female) were included. To avoid the effect of age, we limited our analysis to the 100 subjects aged 65 years old and less. Fifty-one had completed at least one of the neuropsychological tests. We found a positive correlation between PTH levels and the HADS anxiety scores (r=0.23, P=0.01) and a negative one with MMS scores (r=−0.13, P=0.03). A Wilcoxon matched-pairs signed-rank test showed an improvement in MMS (P=0.04), anxiety (P=0.01) and depression (P=0.02) scores in the 16 operated patients.
Conclusion: The severity of PHPT as evaluated by serum markers is correlated with impaired cognitive functions, increased anxiety and depression. These alterations may be reversible upon treatment by parathyroidectomy.
Article tools
My recent searches
My recently viewed abstracts
Authors
Endocrine Abstracts
ISSN 1470-3947 (print) | ISSN 1479-6848 (online)
© Bioscientifica 2026 |
Privacy policy |
Cookie settings
BiosciAbstracts
Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.
Find out more